Wal-Mart Up on Higher Sales

Goldman raises Yahoo and Google estimates; FDA may classify new Pfizer drug a controlled substance; plus more of Monday's stocks in the news

Wal-Mart (WMT ) estimates U.S. same-store sales will be up 3% for December. The retailer notes both food and general merchandise sales were above plan, and gift card redemption was up significantly over last year.

Goldman reportedly raised its estimates on Yahoo (YHOO ) and Google (GOOG ).

Pfizer (PFE ) drug to treat persistent nerve pain, Lyrica, may be classified as a controlled substance, even as the FDA finally approved it for sale, according to the Wall Street Journal.

Sun Microsystems (SUNW ) slipped after Bernstein reportedly downgrades to underperform from market perform.

Wells Fargo reportedly downgraded Gap (GPS ) to hold from buy.

Walgreen (WAG ) posted 31 cents, vs. 25 cents first-quarter earnings per share on a 13% sales rise and 9.4% higher total same-store sales.

TiVo (TIVO ) announced its TiVoToGo service enhancement which allows subscribers to transfer programs from their TiVo box to a laptop to view programs anywhere, anytime is now available.

JP Morgan reportedly downgraded Boston Scientific (BSX ) to neutral from overweight.

A French newspaper reports that Quiksilver (ZQK ) is looking to buy Skis Rossignol, a French sports, clothing, and equipment maker.

JP Morgan reportedly upgrades Stryker Corp. (SYK ) to overweight from neutral.

Banc of America upgrades Marsh & McLennan (MMC ) to buy from neutral and raises their 12-month target to $39.

SuperGen (SUPG ) withdrew its New Drug Application (NDA) for Orathecin Capsules (for treatment of pancreatic cancer) based on feedback indicating that its current data package would not be sufficient to gain approval at this time in U.S.

Raymond James upgraded Williams-Sonoma (WSM ) to strong buy from market perform.

Lehman reportedly upgraded Six Flags (PKS ) to overweight from equal-weight.

Hollinger International (HLR ) says the New York Stock Exchange (NYSE) has granted the company an extension of up to an additional three months to file its Annual Report on Form 10-K for 2003 with the SEC, during which time company's stock will remain listed on the NYSE.

Bear Stearns downgraded Metris Cos. (MXT ) to peer perform from outperform based on valuation.

Delphi Financial Group (DFG ) identified certain potential issues concerning past insurance solicitation practices involving its Safety National unit Marsh & McLennan. Suspends the two Safety employees responsible for its relationship with Marsh & McLennan.

Cray Inc. (CRAY ) received new advance orders with an aggregate value of about $9 million from unnamed European and Asia-Pacific customers for Cray X1E supercomputer systems. The company says the systems are scheduled to be installed in the first half of 2005.

Anteon International (ANT ) received a $69 million task order from Naval Sea Systems Command (NAVSEA) to support the Assistant Secretary of the Navy for Research and Development and the Acquisition Chief Engineer.

AtheroGenics (AGIX ) proposed amendments to its Arise clinical trial which includes increasing patient enrollment and a decreased target number of clinical events. With proposed changes, the company expects the trial should be completed by the end of first-quarter 2006.

Identix (IDNX ) says it has been selected by an unnamed Middle Eastern country to supply and integrate its ABIS biometric data-mining platform and search engines into the country's National Identification program.

Before it's here, it's on the Bloomberg Terminal.